These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27314282)

  • 1. CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma.
    Dai W; Miao H; Fang S; Fang T; Chen N; Li M
    Mol Med Rep; 2016 Aug; 14(2):1509-14. PubMed ID: 27314282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
    Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin-dependent kinase inhibitor 3 is overexpressed in hepatocellular carcinoma and promotes tumor cell proliferation.
    Xing C; Xie H; Zhou L; Zhou W; Zhang W; Ding S; Wei B; Yu X; Su R; Zheng S
    Biochem Biophys Res Commun; 2012 Mar; 420(1):29-35. PubMed ID: 22390936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer.
    Barrón EV; Roman-Bassaure E; Sánchez-Sandoval AL; Espinosa AM; Guardado-Estrada M; Medina I; Juárez E; Alfaro A; Bermúdez M; Zamora R; García-Ruiz C; Gomora JC; Kofman S; Pérez-Armendariz EM; Berumen J
    PLoS One; 2015; 10(9):e0137397. PubMed ID: 26372210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDKN3 knockdown reduces cell proliferation, invasion and promotes apoptosis in human ovarian cancer.
    Zhang LP; Li WJ; Zhu YF; Huang SY; Fang SY; Shen L; Gao YL
    Int J Clin Exp Pathol; 2015; 8(5):4535-44. PubMed ID: 26191143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-Regulated NRSN2 Promotes Cell Proliferation and Survival Through PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma.
    Wang X; Han L; Zhang J; Xia Q
    Dig Dis Sci; 2015 Oct; 60(10):3011-8. PubMed ID: 26055238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin-Dependent Kinase Inhibitor 3 Promotes Cancer Cell Proliferation and Tumorigenesis in Nasopharyngeal Carcinoma by Targeting p27.
    Wang H; Chen H; Zhou H; Yu W; Lu Z
    Oncol Res; 2017 Nov; 25(9):1431-1440. PubMed ID: 28109073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDKN3 regulates cisplatin resistance to colorectal cancer through TIPE1.
    Li WH; Zhang L; Wu YH
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3614-3623. PubMed ID: 32329836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen-related receptor γ is upregulated in liver cancer and its inhibition suppresses liver cancer cell proliferation via induction of p21 and p27.
    Kim JH; Choi YK; Byun JK; Kim MK; Kang YN; Kim SH; Lee S; Jang BK; Park KG
    Exp Mol Med; 2016 Mar; 48(3):e213. PubMed ID: 26940882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
    Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YY1 suppresses proliferation and migration of pancreatic ductal adenocarcinoma by regulating the CDKN3/MdM2/P53/P21 signaling pathway.
    Liu D; Zhang J; Wu Y; Shi G; Yuan H; Lu Z; Zhu Q; Wu P; Lu C; Guo F; Chen J; Jiang K; Miao Y
    Int J Cancer; 2018 Apr; 142(7):1392-1404. PubMed ID: 29168185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway.
    Wei S; Xiong M; Zhan DQ; Liang BY; Wang YY; Gutmann DH; Huang ZY; Chen XP
    Carcinogenesis; 2012 Mar; 33(3):538-47. PubMed ID: 22226916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin-dependent kinase inhibitor 3 (CDKN3) novel cell cycle computational network between human non-malignancy associated hepatitis/cirrhosis and hepatocellular carcinoma (HCC) transformation.
    Wang L; Sun L; Huang J; Jiang M
    Cell Prolif; 2011 Jun; 44(3):291-9. PubMed ID: 21535270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDKN3 expression predicates poor prognosis and regulates adriamycin sensitivity in hepatocellular carcinoma
    Dai W; Fang S; Cai G; Dai J; Lin G; Ye Q; Miao H; Chen M; Tan X; Chen N; Liu X; Li M
    J Int Med Res; 2020 Jul; 48(7):300060520936879. PubMed ID: 32721244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of Cyclin-Dependent Kinase Inhibitor 3 Inhibits Proliferation and Invasion in Human Gastric Cancer Cells.
    Li Y; Ji S; Fu LY; Jiang T; Wu D; Meng FD
    Oncol Res; 2017 May; 25(5):721-731. PubMed ID: 27983933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulated TRIM11 Exerts its Oncogenic Effects in Hepatocellular Carcinoma Through Inhibition of P53.
    Liu J; Rao J; Lou X; Zhai J; Ni Z; Wang X
    Cell Physiol Biochem; 2017; 44(1):255-266. PubMed ID: 29190611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing cyclin-dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines.
    Deng M; Wang J; Chen Y; Zhang L; Xie G; Liu Q; Zhang T; Yuan P; Liu D
    Mol Med Rep; 2016 Aug; 14(2):1523-30. PubMed ID: 27314680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2.
    Fornari F; Milazzo M; Chieco P; Negrini M; Marasco E; Capranico G; Mantovani V; Marinello J; Sabbioni S; Callegari E; Cescon M; Ravaioli M; Croce CM; Bolondi L; Gramantieri L
    J Pathol; 2012 Jul; 227(3):275-85. PubMed ID: 22262409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The centrosomal protein Tax1 binding protein 2 is a novel tumor suppressor in hepatocellular carcinoma regulated by cyclin-dependent kinase 2.
    Lai WL; Hung WY; Wong LL; Zhou Y; Leong VY; Lee JM; Ng IO; Jin DY; Ching YP
    Hepatology; 2012 Nov; 56(5):1770-81. PubMed ID: 22610972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.
    Li T; Xue H; Guo Y; Guo K
    Oncol Rep; 2014 Apr; 31(4):1825-31. PubMed ID: 24573179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.